It is also plausible that Lgl1 suppresses tumor formation by restricting NG2 function as a co-receptor for receptor tyrosine kinases, since deregulated PDGFRα and EGFR signaling activity contributes to gliomagenesis40,56 (for review see ref. 57). The gene discussed is LLGL1; the disease is neoplasm.